Genomic Analysis News Today

/PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global High-performance Computing for Life Sciences...

Health News - An analysis of the genomes of more than 1 million people of European ancestry, conducted by several of the world’s leading genomic centers, including Vanderbilt University Medical Center, has identified more than 2,000 independent genetic signals for blood pressure. The findings, published in the journal Nature Genetics, include improved polygenic scores for predicting blood pressure and the discovery of 500 previously unreported genes that affect blood pressure....

Microarray scanners find applications in crop genetics, aiding in the development of genetically modified organisms.Wilmington, Delaware, United States, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global microarray scanners market is estimated to flourish at a CAGR of 7.5% from 2023 to 2031. Transparency Market Research projects that the overall sales revenue for microarray scanners is estimated to reach US$ 1.7 billion by the end of 2031. The integration of AI algo

BarcelonaExcessive consumption of antibiotics contributes to changing the genetic material of bacteria, making them stronger to reproduce and evade the

Dee honored for distinguished research, service to U.S. pork industry; Sundberg for his outstanding leadership, dedication to swine health.

/PRNewswire/ -- The "Advancements in Next-gen Sequencing and Genomic Analysis" report has been added to ResearchAndMarkets.coms offering. New Research...

A new study finds that some people have inherited genetic variants from Neanderthals that make them more likely to be morning people.

Siamak Daneshmand, MD, explores unmet needs in the bladder cancer treatment landscape at ESMO 2023.

Immune checkpoint inhibitors have been associated with improved outcomes for patients with metastatic translocation renal cell carcinoma; however, novel therapies and therapeutic targets are needed for patients within this histologic subset.

"In October 2022, Illumina, Inc. and AstraZeneca formed a strategic research collaboration to expedite the discovery of therapeutic targets by combining their strengths in AI-based genome interpretation and genomic